New imaging technique to improve lung cancer treatment
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
This study is testing a new imaging technique to help doctors better treat lung cancer patients by creating detailed maps of how air moves in the lungs, which can help them avoid damaging healthy tissue during radiation therapy and improve patients' quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11211199 on NIH RePORTER |
What this research studies
This research focuses on developing a novel lung function imaging technique called '4DCT-ventilation' to enhance the management of lung cancer patients undergoing radiation therapy. By utilizing advanced imaging data and processing methods, the study aims to create detailed lung ventilation maps that help doctors avoid irradiating healthy lung tissue. This approach is expected to minimize harmful side effects associated with radiation treatment, ultimately improving the quality of life for patients. The research has progressed from initial studies to early-phase clinical trials, showing promising results that support further investigation and integration into clinical practice.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer patients who are scheduled to receive radiation therapy.
Not a fit: Patients who are not undergoing radiation therapy for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the side effects of radiation therapy for lung cancer patients, leading to improved quality of life.
How similar studies have performed: Other studies have shown promising results with similar imaging techniques, indicating potential for success in this novel approach.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Vinogradskiy, Yevgeniy — Thomas Jefferson University
- Study coordinator: Vinogradskiy, Yevgeniy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.